Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan before cardiopulmonary bypass in coronary artery bypass graft surgery
2007-004674-49Phase 3Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levosimendan in coronary arteriosclerosis and left ventricular systolic dysfunction (LVSD), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Daily SOFA scores. Started Oct 2007; status: terminated.
02
Drugs
levosimendan
03
Conditions
coronary arteriosclerosisleft ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on 2007-004674-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004674-49.